首頁 › 鐮狀細胞病 › 哥倫比亞特區 › Washington
Washington, DC 的 鐮狀細胞病 臨床試驗
20 項針對 鐮狀細胞病 的研究正在 Washington（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
招募中觀察性研究歡迎健康志工
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
Blood Sampling for Research Related to Sickle Cell Disease
招募中觀察性研究歡迎健康志工
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
招募中3 期
- Childrens National Hospital, Washington D.C.
Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
招募中早期第 1 期
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
招募中觀察性研究
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
招募中1 期
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
招募中3 期
- Childrens National Medical Ctr, Washington D.C.
- MedStar Hlth Res Institute, Washington D.C.
Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease
招募中觀察性研究
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
SCD Stem Cell Mobilization and Apheresis Using Motixafortide
招募中1 期
- National Heart, Blood and Lung Institute-Cellular and Molecular Therapy Branch, Bethesda · 距離 7 英里
Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
招募中1/2 期
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
招募中1 期
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
招募中觀察性研究
- Georgetown University, Washington D.C.
- Children's National Hemophilia Center, Washington D.C.
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
招募中2 期
- Center for Cancer and Blood Disorders, Bethesda · 距離 7 英里
Cooperative Assessment of Late Effects for SCD Curative Therapies
招募中觀察性研究
- Children's National Medical Center, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
招募中觀察性研究
- Children's National Hospital (MRD-HCT), Washington D.C.
Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease
招募中2 期
- Children's National Hospital, Washington D.C.
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
招募中2 期
- Children's National Health System, Washington D.C.
Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
招募中2 期
- Children's National Hospital, Washington D.C.
Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease
招募中
- Children's National Hospital, Washington D.C.
Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
招募中
- Children's National Hospital, Washington D.C.
其他城市的 鐮狀細胞病 試驗
- Atlanta, GA22 項研究
- Chicago, IL18 項研究
- Memphis, TN18 項研究
- Philadelphia, PA15 項研究
- Birmingham, AL14 項研究
- New York City, NY13 項研究
- St. Louis, MO12 項研究
- Boston, MA10 項研究
- Durham, NC10 項研究
- Houston, TX10 項研究
- Cincinnati, OH10 項研究
- Greenville, NC9 項研究
Washington 的其他研究
- 癌症（所有類型）58 項研究
- 非小細胞肺癌55 項研究
- 乳癌46 項研究
- 轉移性癌症43 項研究
- 肺癌41 項研究
- 前列腺癌38 項研究
- 肥胖症33 項研究
- 大腸直腸癌29 項研究
- 心血管疾病28 項研究
- 膀胱癌26 項研究
- 急性髓系白血病24 項研究
- 卵巢癌23 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。